miR-155在结肠癌组织中表达的临床病理意义

    Clinical significance of the miR-155 expression in colon cancer tissue

    • 摘要: 目的:探讨结肠癌组织及细胞株中microRNA-155(miR-155)表达的临床病理意义。方法:采用RT-qPCR检测40例结肠癌组织及癌旁组织、结肠癌细胞株中miR-155的mRNA的表达,并对其临床病理指标进行分析,分析抑制miR-155表达对结肠癌细胞增殖、克隆形成及凋亡影响。结果:RT-qPCR检测结果表明40例结肠癌组织中miR-155相对表达量明显高于癌旁组织(P< 0.01)。不同分化结肠癌细胞miR-155相对表达量差异有统计学意义(P< 0.05),其中低分化结肠癌细胞中表达均高于中、高分化结肠癌细胞(P< 0.05~P< 0.01)。miR-155的异常高表达与病人肿瘤较大、分化程度差、淋巴结发生转移情况及远处有转移均有关(P< 0.05~P< 0.01),而与年龄和性别无关(P> 0.05)。抑制miR-155可明显抑制结肠癌细胞增殖、克隆形成。结论:结肠癌组织中高表达miR-155可以作为预测恶性程度、淋巴转移的有效指标,miR-155在结肠癌病人的临床靶向治疗中具有一定的价值。

       

      Abstract: Objective: To investigate the miR-155 expressions in colon cancer tissue and cell strain,and its clinical significance.Methods: The expressions of miR-155 mRNA in 40 cases of colon cancer tissue and adjacent carcinoma tissues,and cell strains were detected using RT-qPCR,and the clinical pathological indicators were analyzed.The effects of the inhibiting miR-155 expression on the proliferation,colony-formation and apoptosis of colon cancer cells were analyzed.Results: The results of RT-qPCR showed that the miR-155 mRNA expression in colon cancer tissues was significantly higher than that in adjacent carcinoma tissues(P<0.01).The difference of the expression of miR-155 in different differentiated colon cancer cells was statistically significant(P<0.05),and the expression of miR-155 in low-differentiated colon cancer cells was higher than that in medium and high-differentiated colon cancer cells(P<0.05 to P<0.01).The abnormally high expression of miR-155 was related to the big tumor size,poor differentiation degree,lymph node metastasis and distant metastasis(P<0.05 to P<0.01),but which was not related to the age and gender(P>0.05).Inhibiting the expression of miR-155 could inhibit the cell proliferation and colony-formation of colon cancer cells.Conclusions: The miR-155 high expression in colon cancer tissues can be used as an effective predictor of malignant degree and lymph node metastasis.The miR-155 has a certain value in the clinical targeted therapy of colon cancer.

       

    /

    返回文章
    返回